Analyzing RushNet (OTCMKTS:RSHN) & Danaher (NYSE:DHR)

Danaher (NYSE:DHR) and RushNet (OTCMKTS:RSHN) are both multi-sector conglomerates companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, risk, earnings, dividends and analyst recommendations.

Profitability

This table compares Danaher and RushNet’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Danaher	17.26%	12.25%	7.43%
RushNet	N/A	N/A	N/A

Earnings and Valuation

This table compares Danaher and RushNet’s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Danaher	$23.89 billion	7.70	$4.76 billion	$6.39	38.94
RushNet	N/A	N/A	N/A	N/A	N/A

Danaher has higher revenue and earnings than RushNet.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Danaher and RushNet, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Danaher	0	6	9	0	2.60
RushNet	0	0	0	0	N/A

Danaher currently has a consensus price target of $266.00, suggesting a potential upside of 6.90%. Given Danaher’s higher probable upside, equities analysts clearly believe Danaher is more favorable than RushNet.

Insider & Institutional Ownership

79.1% of Danaher shares are owned by institutional investors. 11.1% of Danaher shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Danaher beats RushNet on 8 of the 8 factors compared between the two stocks.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

About RushNet

RushNet, Inc. provides laboratory diagnostic testing services. It offers high-complexity urine drug testing, behavioral drug testing, allergy droplet cards, oral fluids, and infectious disease services. The company is based in Jacksonville, Florida.